One study found that CSF-1 blockade decreased neuroblastoma tumor growth in vivo and prolonged survival in the SK-NDZ neuroblastoma xenograft model, in which tumor cells do not express human CSF-1 (121). This evidence concerns the gene CSF1 and neoplasm.